Highly Synergistic Effects of Melittin with Vancomycin against Vancomycin Resistant Staphylococcus aureus

Highly Synergistic Effects of Melittin with Vancomycin against Vancomycin Resistant Staphylococcus aureus


چاپ صفحه
پژوهان
صفحه نخست سامانه
نویسندگان
نویسندگان
اطلاعات تفضیلی
اطلاعات تفضیلی
دانلود مقاله
دانلود مقاله
دانشگاه علوم پزشکی تبریز
دانشگاه علوم پزشکی تبریز

نویسندگان: لیلا رهبرنیا , محمدحسین غفاری اقدم

عنوان کنگره / همایش: 23 کنگره بین المللی میکروبیولوژی , Iran (Islamic Republic) , تهران , 2022

اطلاعات کلی مقاله
hide/show

نویسنده ثبت کننده مقاله لیلا رهبرنیا
مرحله جاری مقاله تایید نهایی
دانشکده/مرکز مربوطه بیماری های عفونی و گرمسیری
کد مقاله 83664
عنوان فارسی مقاله Highly Synergistic Effects of Melittin with Vancomycin against Vancomycin Resistant Staphylococcus aureus
عنوان لاتین مقاله Highly Synergistic Effects of Melittin with Vancomycin against Vancomycin Resistant Staphylococcus aureus
نوع ارائه پوستر
عنوان کنگره / همایش 23 کنگره بین المللی میکروبیولوژی
نوع کنگره / همایش بین المللی
کشور محل برگزاری کنگره/ همایش Iran (Islamic Republic)
شهر محل برگزاری کنگره/ همایش تهران
سال انتشار/ ارائه شمسی 1401
سال انتشار/ارائه میلادی 2022
تاریخ شمسی شروع و خاتمه کنگره/همایش 1401/06/08 الی 1401/06/10
آدرس لینک مقاله/ همایش در شبکه اینترنت
آدرس علمی (Affiliation) نویسنده متقاضی Infectious and Tropical Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

نویسندگان
hide/show

نویسنده نفر چندم مقاله
لیلا رهبرنیاسوم
محمدحسین غفاری اقدماول

اطلاعات تفضیلی
hide/show

عنوان متن
کلمات کلیدیStaphylococcus aureus, vancomycin-resistant, melittin peptide, synergism
خلاصه مقالهMultidrug resistance Staphylococcus aureus(MDR) strains are increasingly emerging as serious threat for public health. Moreover, the use of vancomycin as last resort antibiotic for the treatment of MDR infections is limited because of severe toxicity in high doses The antimicrobial activity of melittin is now confirmed against a wide variety of bacteria. However, the high toxicity is one of the limiting factors for the therapeutic application of Melittin. The combinational therapy is one of strategies used to reduce toxicity of drugs because decrease of dose of drug. In this study, the antibacterial effect of melittin peptide in combination with vancomycin was evaluated to control vancomycin resistant(VRSA) clinical isolates. Methods: In this study, melittin was purified from Iranian honey bee venom by reversed-phase HPLC. Minimum inhibitory concentration (MIC), minimum bactericidal concentration (MBC) of antimicrobial agents were determined against VRSA isolates. The cytotoxicity of melittin on HUVEK cells and human red blood cells (RBCs) was evaluated at their synergistic concentrations. Results: MIC and MBC values for melittin were equal to 16 and 32, respectively. Results also showed that the interaction of melittin with vancomycin was highly synergistic. Induced synergism led to a decrease in melittin and vancomycin concentrations by 32 and 16-folds, respectively. So that, only 0.25 ?g/mL melittin in combination with 0.125 ?g/mL vancomycin was sufficient to inhibit VRSA isolates growth. Based on Hemolytic and MTT assay results, Melittin did not show toxic effects at 0.25?g/ml as the synergistic concentration. Conclusion: our findings indicated that melittin showed highly synergistic effects with vancomycin with reduced toxicity. Therefore, the combination of melittin and traditional antibiotics could be a promising strategy for the treatment of VRSA infections.

لینک دانلود مقاله
hide/show

نام فایل تاریخ درج فایل اندازه فایل دانلود
abstract synegism.pdf1402/10/11370425دانلود
Ism_certificate (2).pdf1402/10/1122430201دانلود